STAT3 and cancer: Studies have shown that metformin specifically inhibits the nuclear translocation of NF-κB and the phosphorylation of STAT3, thereby suppressing the inflammatory response associated with the growth of cancer stem cells (CSCs) and cellular transformation [143,144].